全球醫藥物流市場：市場規模和佔有率分析 - 趨勢、驅動因素、競爭狀況、未來預測（2024-2030）

主要亮點

預計2023年全球醫藥物流市場規模將達929億美元，2030年將達1737億美元，複合年增長率超過9.0%。

冷鏈產業的發展是產業擴張的主要因素。

醫藥冷鏈產業多年來成長顯著，冷鏈物流在醫藥產業取得了長足的發展，各種藥品的需求正在快速成長。

關鍵見解

由於運輸是物流鏈的重要組成部分，2023年對該行業的貢獻最大，佔有率約為55%。

化學藥品類別在2023年佔比最大，約45%，主要是由於製藥公司對活性藥物成分的需求增加。

2023年，海運品類引領產業，約佔50%佔有率。 海運可以輕鬆容納專用冷藏貨櫃，使供應鏈更有條理。

歐洲在這一行業中處於領先地位，並將在未來 10 年以 9.6% 的複合年增長率進一步增長。

在印度、中國和日本製藥和醫療產業崛起的推動下，亞太地區預計將以近十年來最快的複合年增長率發展。

本報告分析了全球醫藥物流市場，包括市場的基本結構和最新情況、主要促進和限制因素以及全球、分地區和主要國家（依貨幣計算）市場規模的前景。 ），依類型、應用、運輸工具和組件劃分的詳細趨勢、市場競爭現狀以及主要公司概況。

目錄

第一章研究範圍

第二章研究方法

第 3 章執行摘要

第 4 章市場指標

第五章產業展望

• 市場動態
  • 趨勢
  • 促進因素
  • 抑制因素/課題
  • 促進/抑制因子影響分析
• 新型冠狀病毒感染 (COVID-19) 的影響
• 波特五力分析

第六章世界市場

• 摘要
• 市場收入：依類型劃分（2017-2030 年）
• 市場收入：依應用分類（2017-2030 年）
• 市場收入：以運輸方式分類（2017-2030 年）
• 市場收入：依組成部分劃分（2017-2030 年）
• 市場收入：依地區劃分（2017-2030 年）

第七章北美市場

• 摘要
• 市場收入：依類型劃分（2017-2030 年）
• 市場收入：依應用分類（2017-2030 年）
• 市場收入：以運輸方式分類（2017-2030 年）
• 市場收入：依組成部分劃分（2017-2030 年）
• 市場收入：依國家/地區劃分（2017-2030 年）

第八章歐洲市場

第9章亞太市場

第10章拉丁美洲市場

第十一章中東及非洲市場

第12章美國市場

• 摘要
• 市場收入：依類型劃分（2017-2030 年）
• 市場收入：依應用分類（2017-2030 年）
• 市場收入：以運輸方式分類（2017-2030 年）
• 市場收入：依組成部分劃分（2017-2030 年）

第十三章加拿大市場

第14章德國市場

第十五章法國市場

第十六章英國市場

第十七章義大利市場

第十八章西班牙市場

第十九章日本市場

第20章中國市場

第21章印度市場

第22章澳洲市場

第23章韓國市場

第24章巴西市場

第25章墨西哥市場

第26章沙烏地阿拉伯市場

第27章南非市場

第 28 章阿聯酋 (UAE) 市場

第29章競爭態勢

• 市場參與者及其提供的產品/服務的列表
• 主要公司的競爭基準
• 各大公司的產品基準
• 近期策略發展狀況

第30章公司簡介

• Agility Public Warehousing Company K.S.C.P.
• Deutsche Post AG
• Yusen Logistics Co. Ltd.
• CEVA
• Kerry Logistics Network Limited
• Kuehne+Nagel
• Federal Express Canada Corporation
• CWT Pte. Limited
• GEMADEPT
• Delhivery Limited
• Singapore Post Limited
• Cencora Inc.
• SF Express Co. Ltd.
• YCH Group

第31章附錄

Key Highlights

The pharmaceutical logistics market was valued at USD 92.9 billion in 2023, and it will increase to USD 173.7 billion, advancing at over 9.0% compound annual growth rate, by 2030.

Development in the cold-chain sector is a key factor driving the industry expansion.

The pharma cold-chain sector has grown significantly over the years, and cold-chain logistics accounted for a significant development in the pharmaceutical sector, with a surging need for various drugs.

The industry, during the pandemic of COVID-19, performed admirably, even though most vaccine products required a stringent temperature regime (-80 °C), which had hardly been seen before.

Many pharma cold-chain firms, to deal with the emergency, increased their capacity and raised their service levels, and these adjustments are now helping the pharma logistics companies.

Technological improvement is a major trend being witnessed in this industry. RFID allows pallet-level tracking and identification of pharmaceutical goods, therefore, assisting the supply chain authenticity by sustaining optimum hygiene, preserving product integrity, and decreasing cold chain transport losses.

Major pharmaceutical firms are resorting to industry clouds to boost the move of important workloads to the cloud and address most of these challenges.

The main aspects of the cloud for this market are ERP, supply chain orchestration systems and control towers, quality control solutions for laboratories, and MES systems.

Key Insights

Transportation was the largest contributor to the industry in 2023, with a share of approximately 55%, as transportation is an important part of the logistics chain.

The swift rise in the requirement for medicines after the pandemic has boosted inter-country trade volumes of medicines, which, sequentially, assist the expansion of the transportation sector.

The cold-chain category was the largest contributor to the industry in 2023, and it will also advance at the highest rate, of approximately 9.7%, in the years to come.

The widespread import and export of vaccines have resulted in the expansion of the cold-chain category since the pandemic of COVID-19.

The chemical pharma category accounted for the largest share in 2023, of approximately 45%, mainly because of drug businesses' rising need for APIs.

The growing prevalence of chronic ailments has a major impact on the rising need for chemical pharmaceutical logistics.

The seaways category led the industry in 2023, with a share of approximately 50%. Sea transport can house dedicated refrigerated containers (reefers) easily, allowing greater supply chain organization.

Despite the high risk involved in medication handling, sea carriers seem the finest place to control the complete pharma shipping procedure with refrigeration mechanisms.

Europe is leading the industry, and it will further advance at a 9.6% compound annual growth rate during this decade.

The substantial rise in the trade of pharmaceutical goods across major European nations like the U.K., France, and Germany, is accountable for the leading position of the regional industry.

APAC will advance at the fastest CAGR during this decade, because of the flourishing pharmaceutical and healthcare sectors in India, China, and Japan.

The pharmaceutical logistics industry is very fragmented, with several players operating worldwide. These players are continuously looking for growth strategies like acquiring other businesses to maintain their position in the market.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by type
  • 1.4.2. Market size breakdown, by application
  • 1.4.3. Market size breakdown, by mode of transportation
  • 1.4.4. Market size breakdown, by Component
  • 1.4.5. Market size breakdown, by region
  • 1.4.6. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Type (2017-2030)
• 6.3. Market Revenue, by Application (2017-2030)
• 6.4. Market Revenue, by Mode of Transportation (2017-2030)
• 6.5. Market Revenue, by Component (2017-2030)
• 6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Type (2017-2030)
• 7.3. Market Revenue, by Application (2017-2030)
• 7.4. Market Revenue, by Mode of Transportation (2017-2030)
• 7.5. Market Revenue, by Component (2017-2030)
• 7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Type (2017-2030)
• 8.3. Market Revenue, by Application (2017-2030)
• 8.4. Market Revenue, by Mode of Transportation (2017-2030)
• 8.5. Market Revenue, by Component (2017-2030)
• 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Type (2017-2030)
• 9.3. Market Revenue, by Application (2017-2030)
• 9.4. Market Revenue, by Mode of Transportation (2017-2030)
• 9.5. Market Revenue, by Component (2017-2030)
• 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Type (2017-2030)
• 10.3. Market Revenue, by Application (2017-2030)
• 10.4. Market Revenue, by Mode of Transportation (2017-2030)
• 10.5. Market Revenue, by Component (2017-2030)
• 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Type (2017-2030)
• 11.3. Market Revenue, by Application (2017-2030)
• 11.4. Market Revenue, by Mode of Transportation (2017-2030)
• 11.5. Market Revenue, by Component (2017-2030)
• 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Type (2017-2030)
• 12.3. Market Revenue, by Application (2017-2030)
• 12.4. Market Revenue, by Mode of Transportation (2017-2030)
• 12.5. Market Revenue, by Component (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Type (2017-2030)
• 13.3. Market Revenue, by Application (2017-2030)
• 13.4. Market Revenue, by Mode of Transportation (2017-2030)
• 13.5. Market Revenue, by Component (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Type (2017-2030)
• 14.3. Market Revenue, by Application (2017-2030)
• 14.4. Market Revenue, by Mode of Transportation (2017-2030)
• 14.5. Market Revenue, by Component (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Type (2017-2030)
• 15.3. Market Revenue, by Application (2017-2030)
• 15.4. Market Revenue, by Mode of Transportation (2017-2030)
• 15.5. Market Revenue, by Component (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Type (2017-2030)
• 16.3. Market Revenue, by Application (2017-2030)
• 16.4. Market Revenue, by Mode of Transportation (2017-2030)
• 16.5. Market Revenue, by Component (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Type (2017-2030)
• 17.3. Market Revenue, by Application (2017-2030)
• 17.4. Market Revenue, by Mode of Transportation (2017-2030)
• 17.5. Market Revenue, by Component (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Type (2017-2030)
• 18.3. Market Revenue, by Application (2017-2030)
• 18.4. Market Revenue, by Mode of Transportation (2017-2030)
• 18.5. Market Revenue, by Component (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Type (2017-2030)
• 19.3. Market Revenue, by Application (2017-2030)
• 19.4. Market Revenue, by Mode of Transportation (2017-2030)
• 19.5. Market Revenue, by Component (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Type (2017-2030)
• 20.3. Market Revenue, by Application (2017-2030)
• 20.4. Market Revenue, by Mode of Transportation (2017-2030)
• 20.5. Market Revenue, by Component (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Type (2017-2030)
• 21.3. Market Revenue, by Application (2017-2030)
• 21.4. Market Revenue, by Mode of Transportation (2017-2030)
• 21.5. Market Revenue, by Component (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Type (2017-2030)
• 22.3. Market Revenue, by Application (2017-2030)
• 22.4. Market Revenue, by Mode of Transportation (2017-2030)
• 22.5. Market Revenue, by Component (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Type (2017-2030)
• 23.3. Market Revenue, by Application (2017-2030)
• 23.4. Market Revenue, by Mode of Transportation (2017-2030)
• 23.5. Market Revenue, by Component (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Type (2017-2030)
• 24.3. Market Revenue, by Application (2017-2030)
• 24.4. Market Revenue, by Mode of Transportation (2017-2030)
• 24.5. Market Revenue, by Component (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Type (2017-2030)
• 25.3. Market Revenue, by Application (2017-2030)
• 25.4. Market Revenue, by Mode of Transportation (2017-2030)
• 25.5. Market Revenue, by Component (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Type (2017-2030)
• 26.3. Market Revenue, by Application (2017-2030)
• 26.4. Market Revenue, by Mode of Transportation (2017-2030)
• 26.5. Market Revenue, by Component (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Type (2017-2030)
• 27.3. Market Revenue, by Application (2017-2030)
• 27.4. Market Revenue, by Mode of Transportation (2017-2030)
• 27.5. Market Revenue, by Component (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Type (2017-2030)
• 28.3. Market Revenue, by Application (2017-2030)
• 28.4. Market Revenue, by Mode of Transportation (2017-2030)
• 28.5. Market Revenue, by Component (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Agility Public Warehousing Company K.S.C.P.
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Deutsche Post AG
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Yusen Logistics Co. Ltd.
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. CEVA
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Kerry Logistics Network Limited
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Kuehne+Nagel
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Federal Express Canada Corporation
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. CWT Pte. Limited
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. GEMADEPT
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. Delhivery Limited
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary
• 30.11. Singapore Post Limited
  • 30.11.1. Business overview
  • 30.11.2. Product and service offerings
  • 30.11.3. Key financial summary
• 30.12. Cencora Inc.
  • 30.12.1. Business overview
  • 30.12.2. Product and service offerings
  • 30.12.3. Key financial summary
• 30.13. SF Express Co. Ltd.
  • 30.13.1. Business overview
  • 30.13.2. Product and service offerings
  • 30.13.3. Key financial summary
• 30.14. YCH Group
  • 30.14.1. Business overview
  • 30.14.2. Product and service offerings
  • 30.14.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports